Merck Partners with China’s BGI on Genomics

Did you know?

ChinaBio^® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…

More white papers:

>>China Partnering 2012: Driving Future Innovation

>>China Life Science 2012: From Local to Global

Free Content

Week in Review

In My Opinion

Free Articles

Education Center

Interfax-BW Releases

Subscriber Content

Merck Partners with China’s BGI on Genomics

publication date: Sep 13, 2011

Merck, known as MSD outside North America, has formally launched a collaboration with BGI, the Shenzhen-based genomics powerhouse. The two companies will seek to discover and develop biomarkers as a means toward drug discovery, drug development and diagnostics applications. In September 2010, the two entities signed an agreement to explore ways to work together, and this partnership is the result. More details....

Stock Symbol: (NYSE: MRK) Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Click here to join.